Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.
Severe Cases of COVID-19 Are Associated with Changes in Circulating Small RNA
21 Pages Posted: 17 May 2021
More...Abstract
RNA-interference is described as an evolutionary conserved host defense mechanism against viral infection. Up to now, the relevance of this mechanism for SARS-CoV-2-directed immune responses remains elusive.
Here, we used high throughput sequencing to profile the plasma of active and convalescent COVID-19 patients for the presence of small circulating RNAs. The presence of SARS-CoV-2 derived small RNAs in plasma samples of mild and severe COVID-19 cases is described. Clusters of high siRNA abundance were discovered, homologous to the nsp2 3´-end and nsp4 virus sequence. Four virus derived small RNA sequences have the size of human miRNAs and target search revealed candidate genes associated with ageusia and long COVID symptoms. These virus-derived small RNAs are detectable also after recovery from the disease.
The additional analysis of circulating human miRNAs revealed differentially abundant miRNAs discriminating mild from severe cases. 29 miRNAs are reduced or absent in severe cases. Several of these are associated with the Interferon JAK-STAT response (e.g. hsa-miRNA4516, hsa-miR-320 b, c and d, hsa-miR-126-3p).
Funding Statement: This project was partially funded by the German Research Foundation (CRC 841, to MB) as well as by the Martin-Luther-University Halle (Saale) and Leibniz Institute of Plant Genetics and Crop Plant Research, Gatersleben, Germany.
Declaration of Interests: The authors have no conflict of interests.
Ethics Approval Statement: Blood collection was performed under institutional review board approvals numbers 2020- 039 and 11/17.
Keywords: SARS-CoV-2, COVID-19, long COVID, small RNA, circulating-miRNA
Suggested Citation: Suggested Citation